Equity Overview
Price & Market Data
Price: $0.97
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $39,852,160
Volume: 0
Performance Metrics
1 Week: 2.11%
1 Month: -38.61%
3 Months: -39.76%
6 Months: -50.55%
1 Year: -65.11%
YTD: -42.26%
Company Details
Employees: 3
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. The company was incorporated in 2020 and is based in Lakeway, Texas.